Victoria Richon

Insider Reports History

Location
Cambridge, MA
Signature
/s/ John Weidenbruch, attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Victoria Richon:

Company Role Class Num Shares Value Price $ Report Date Ownership
Epizyme, Inc. Director Stock Option (Right to Buy) 41,006 $22,963 $0.5600 17 May 2022 Direct
Epizyme, Inc. Director Common Stock, par value $0.0001 0 $1.41 12 Aug 2022 Direct

Insider Reports Filed by Victoria Richon

Symbol Company Period Transactions Value $ Form Type Role Filing Time
/report/000089924322028870-richon-victoria-2022-08-12 Epizyme, Inc. 12 Aug 2022 2 $0 4 Director 16 Aug 2022, 18:59
/report/000089924322018840-richon-victoria-2022-05-17 Epizyme, Inc. 17 May 2022 2 $0 4 Director 19 May 2022, 16:29
/report/000089924321023863-richon-victoria-2021-06-11 Epizyme, Inc. 11 Jun 2021 2 $0 4 Director 15 Jun 2021, 16:32